• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去脂体重指数:连接慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠患者肺部、睡眠及全身因素的关键指标。

FFMI: A Pivotal Indicator Bridging Pulmonary, Sleep, and Systemic Factors in COPD-OSA Overlap Patients.

作者信息

Wang Liang, Shen Ying-Ying, Qian Rui-Qi, Zhang Xiu-Qin, Shen Xu-Rui, Chen Cheng

机构信息

Department of Emergency Medicine, the First Affiliated Hospital of Soochow University, Suzhou, People's Republic of China.

Department of Critical Care Medicine, Linyi People's Hospital, Linyi, People's Republic of China.

出版信息

Int J Chron Obstruct Pulmon Dis. 2025 Jun 10;20:1843-1849. doi: 10.2147/COPD.S514400. eCollection 2025.

DOI:10.2147/COPD.S514400
PMID:40524722
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12168911/
Abstract

OBJECTIVE

Overlap Syndrome (OVS), combining Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA), is common yet often unrecognized. This study aims to compare the Fat - Free Mass Index (FFMI) between OVS and simple COPD patients and analyze subgroup differences in OVS for better early identification and severity assessment.

METHODS

Clinical data of 364 patients (203 in COPD group, 161 in OVS group) were analyzed regarding clinical features, pulmonary function, sleep apnea, etc. The OVS group was divided into low-FFMI and normal-FFMI subgroups (the cutoff value of FFMI < 17kg/m²) for correlation analysis.

RESULTS

Statistically significant differences in frequency of acute exacerbations and hospitalizations in the past year, and comorbidities were observed between the COPD group and OVS group (all p < 0.05). The OVS group exhibited significantly lower FEV%pred, FEV /FVC, 6MWT, FFMI, and L-SaO compared to the COPD group (all p < 0.05), while AHI, ESS, CAT, and MMRC were higher. Patients with lower FFMI demonstrated lower FEV%pred, FEV/FVC, L-SaO2, and 6MWT than those with normal FFMI. Additionally, AHI, MMRC, frequency of acute exacerbations, and hospitalizations in the past year were higher (all p < 0.05) in this group. Correlation analysis revealed that in the OVS group, FFMI positively correlated with FEV1%pred and FEV1/FVC, and negatively with AHI, MMRC, exacerbation/hospitalization frequency.

CONCLUSION

OVS patients had distinct features like more exacerbations, and lower lung function. The OVS subgroup with different FFMI showed significant differences in lung function and sleep indices. FFMI is closely related to pulmonary function, sleep disorder indices, and exacerbation frequency, suggesting its potential as an important indicator for early OVS identification and severity evaluation despite no significant difference in BMI.

摘要

目的

重叠综合征(OVS),即慢性阻塞性肺疾病(COPD)与阻塞性睡眠呼吸暂停(OSA)并存,较为常见但常未被识别。本研究旨在比较OVS患者与单纯COPD患者的去脂体重指数(FFMI),并分析OVS患者的亚组差异,以实现更好的早期识别和严重程度评估。

方法

分析364例患者(COPD组203例,OVS组161例)的临床资料,包括临床特征、肺功能、睡眠呼吸暂停等。将OVS组分为低FFMI亚组和正常FFMI亚组(FFMI临界值<17kg/m²)进行相关性分析。

结果

COPD组与OVS组在过去一年的急性加重频率、住院次数及合并症方面存在统计学显著差异(均p<0.05)。与COPD组相比,OVS组的FEV%pred、FEV/FVC、6分钟步行试验(6MWT)、FFMI及最低血氧饱和度(L-SaO)显著更低(均p<0.05),而呼吸暂停低通气指数(AHI)、Epworth嗜睡量表(ESS)、慢性阻塞性肺疾病评估测试(CAT)及改良英国医学研究委员会呼吸困难量表(MMRC)更高。FFMI较低的患者,其FEV%pred、FEV/FVC、L-SaO₂及6MWT低于FFMI正常的患者。此外,该组患者的AHI、MMRC、过去一年的急性加重频率及住院次数更高(均p<0.05)。相关性分析显示,在OVS组中,FFMI与FEV1%pred和FEV1/FVC呈正相关,与AHI、MMRC、加重/住院频率呈负相关。

结论

OVS患者具有急性加重更多、肺功能更低等独特特征。不同FFMI的OVS亚组在肺功能和睡眠指标方面存在显著差异。FFMI与肺功能、睡眠障碍指标及加重频率密切相关,表明尽管体重指数(BMI)无显著差异,但FFMI有潜力作为OVS早期识别和严重程度评估的重要指标。

相似文献

1
FFMI: A Pivotal Indicator Bridging Pulmonary, Sleep, and Systemic Factors in COPD-OSA Overlap Patients.去脂体重指数:连接慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停重叠患者肺部、睡眠及全身因素的关键指标。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 10;20:1843-1849. doi: 10.2147/COPD.S514400. eCollection 2025.
2
COTE and Pulmonary Comorbidities Predict Moderate-to-Severe Acute Exacerbation and Hospitalization in COPD.慢性阻塞性肺疾病评估测试(COTE)与肺部合并症可预测慢性阻塞性肺疾病(COPD)的中重度急性加重和住院情况。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 11;20:1893-1913. doi: 10.2147/COPD.S518218. eCollection 2025.
3
Association of Patient-Reported Outcome Patterns and Major Clinical Factors with Frailty in Stable COPD.稳定期慢性阻塞性肺疾病患者报告结局模式及主要临床因素与衰弱的关联
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1927-1937. doi: 10.2147/COPD.S517270. eCollection 2025.
4
Effect of lung function on the apnea-hypopnea index in patients with overlap syndrome: a multicenter cross-sectional study.肺功能对重叠综合征患者睡眠呼吸暂停低通气指数的影响:一项多中心横断面研究。
Sleep Breath. 2020 Sep;24(3):1059-1066. doi: 10.1007/s11325-019-01961-w. Epub 2019 Nov 25.
5
[Correlation of body composition indicators with exercise capacity and nutritional status in male patients with chronic obstructive pulmonary disease].[慢性阻塞性肺疾病男性患者身体成分指标与运动能力及营养状况的相关性]
Zhonghua Yi Xue Za Zhi. 2024 Sep 24;104(36):3402-3408. doi: 10.3760/cma.j.cn112137-20240129-00227.
6
Influence of Urinary Incontinence Related Factors on Health-Related Quality of Life in Patients with Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study.尿失禁相关因素对慢性阻塞性肺疾病患者健康相关生活质量的影响:一项横断面研究。
Int J Chron Obstruct Pulmon Dis. 2025 Jun 12;20:1881-1892. doi: 10.2147/COPD.S515494. eCollection 2025.
7
Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry.有吸烟史且肺功能正常者的呼吸道急性加重和肺功能下降
Am J Respir Crit Care Med. 2025 Jun;211(6):957-965. doi: 10.1164/rccm.202401-0023OC.
8
Relationship Between COPD Progression and Frailty Progression: A Five-year Observation in Real Clinical Practice.慢性阻塞性肺疾病进展与衰弱进展之间的关系:真实临床实践中的五年观察
Int J Chron Obstruct Pulmon Dis. 2025 Jun 14;20:1955-1964. doi: 10.2147/COPD.S512326. eCollection 2025.
9
Mucolytics for children with chronic suppurative lung disease.用于患有慢性化脓性肺病儿童的黏液溶解剂。
Cochrane Database Syst Rev. 2025 Mar 28;3(3):CD015313. doi: 10.1002/14651858.CD015313.pub2.
10
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials.恩昔芬净治疗慢性阻塞性肺疾病的疗效与安全性:一项临床试验的系统评价和荟萃分析
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251347775. doi: 10.1177/17534666251347775. Epub 2025 Jun 20.

本文引用的文献

1
Sleep disordered breathing: OSA-COPD overlap.睡眠呼吸紊乱:重叠型阻塞性睡眠呼吸暂停低通气综合征合并慢性阻塞性肺疾病。
Expert Rev Respir Med. 2024 Jun;18(6):369-379. doi: 10.1080/17476348.2024.2373790. Epub 2024 Jul 2.
2
The Role of Nutrition in the Development and Management of Chronic Obstructive Pulmonary Disease.营养在慢性阻塞性肺疾病发生发展及管理中的作用
Nutrients. 2024 Apr 11;16(8):1136. doi: 10.3390/nu16081136.
3
Mortality in obstructive sleep apnea syndrome (OSAS) and overlap syndrome (OS): The role of nocturnal hypoxemia and CPAP compliance.阻塞性睡眠呼吸暂停综合征(OSAS)和重叠综合征(OS)患者的死亡率:夜间低氧血症和 CPAP 依从性的作用。
Sleep Med. 2023 Dec;112:96-103. doi: 10.1016/j.sleep.2023.10.011. Epub 2023 Oct 10.
4
Interaction of BMI and respiratory status in obstructive sleep apnea, a cross-sectional COPD study.BMI 与呼吸状态在阻塞性睡眠呼吸暂停中的相互作用:一项 COPD 的横断面研究。
NPJ Prim Care Respir Med. 2023 Aug 15;33(1):30. doi: 10.1038/s41533-023-00351-w.
5
Impaired Skeletal Muscle in Patients with Stable Chronic Obstructive Pulmonary Disease (COPD) Compared with Non-COPD Patients.稳定期慢性阻塞性肺疾病(COPD)患者的骨骼肌功能受损与非 COPD 患者相比。
Int J Chron Obstruct Pulmon Dis. 2023 Jul 19;18:1525-1532. doi: 10.2147/COPD.S396728. eCollection 2023.
6
Sleep and cardiometabolic comorbidities in the obstructive sleep apnoea-COPD overlap syndrome: data from the European Sleep Apnoea Database.阻塞性睡眠呼吸暂停-慢性阻塞性肺疾病重叠综合征中的睡眠与心脏代谢共病:来自欧洲睡眠呼吸暂停数据库的数据
ERJ Open Res. 2023 Jun 26;9(3). doi: 10.1183/23120541.00676-2022. eCollection 2023 May.
7
Differential impacts between fat mass index and fat-free mass index on patients with COPD.脂肪量指数和去脂体重指数对慢性阻塞性肺疾病患者的不同影响。
Respir Med. 2023 Oct;217:107346. doi: 10.1016/j.rmed.2023.107346. Epub 2023 Jun 28.
8
Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome.阻塞性睡眠呼吸暂停、慢性阻塞性肺疾病和慢性阻塞性肺疾病/阻塞性睡眠呼吸暂停重叠综合征中的炎症生物标志物。
J Clin Sleep Med. 2023 Aug 1;19(8):1447-1456. doi: 10.5664/jcsm.10600.
9
Differential Impact of Low Fat-Free Mass in People With COPD Based on BMI Classifications: Results From the COPD and Systemic Consequences-Comorbidities Network.基于 BMI 分类的 COPD 患者低去脂体重的差异影响:COPD 和系统后果合并症网络的研究结果。
Chest. 2023 May;163(5):1071-1083. doi: 10.1016/j.chest.2022.11.040. Epub 2022 Dec 5.
10
The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.特发性肺纤维化与阻塞性睡眠呼吸暂停之间的关联:一项系统评价与荟萃分析
J Clin Med. 2022 Aug 26;11(17):5008. doi: 10.3390/jcm11175008.